Literature DB >> 28238105

Emerging Role of MicroRNAs in mTOR Signaling.

Yanjie Zhang1, Bo Huang2, Hui-Yun Wang3,4,5, Augustus Chang5, X F Steven Zheng6,7,8.   

Abstract

Mechanistic target of rapamycin (mTOR) is a conserved serine/threonine kinase that plays a critical role in the control of cellular growth and metabolism. Hyperactivation of mTOR pathway is common in human cancers, driving uncontrolled proliferation. MicroRNA (miRNA) is a class of short noncoding RNAs that regulate the expression of a wide variety of genes. Deregulation of miRNAs is a hallmark of cancer. Recent studies have revealed interplays between miRNAs and the mTOR pathway during cancer development. Such interactions appear to provide a fine-tuning of various cellular functions and contribute qualitatively to the behavior of cancer. Here we provide an overview of current knowledge regarding the reciprocal relationship between miRNAs and mTOR pathway: regulation of mTOR signaling by miRNAs and control of miRNA biogenesis by mTOR. Further research in this area may prove important for the diagnosis and therapy of human cancer.

Entities:  

Keywords:  Biomarker; Cancer; Cell signaling pathway; MicroRNA; mTOR

Mesh:

Substances:

Year:  2017        PMID: 28238105      PMCID: PMC5482757          DOI: 10.1007/s00018-017-2485-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  129 in total

1.  Targets of gene amplification and overexpression at 17q in gastric cancer.

Authors:  Asta Varis; Maija Wolf; Outi Monni; Marja-Leena Vakkari; Arto Kokkola; Chris Moskaluk; Henry Frierson; Steven M Powell; Sakari Knuutila; Anne Kallioniemi; Wa'el El-Rifai
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

2.  Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.

Authors:  Weijie Zhang; Pengxu Qian; Xiao Zhang; Min Zhang; Hong Wang; Mingming Wu; Xiangjun Kong; Sheng Tan; Keshuo Ding; Jo K Perry; Zhengsheng Wu; Yuan Cao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2015-04-14       Impact factor: 5.157

3.  miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells.

Authors:  Ruey-Jen Lin; You-Chin Lin; Alice L Yu
Journal:  Mol Carcinog       Date:  2010-08       Impact factor: 4.784

4.  Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.

Authors:  Mabrouka Doghman; Abeer El Wakil; Bruno Cardinaud; Emilie Thomas; Jinling Wang; Wei Zhao; Maria Helena C Peralta-Del Valle; Bonald C Figueiredo; Gerard P Zambetti; Enzo Lalli
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 5.  MiR-218 mediates tumorigenesis and metastasis: Perspectives and implications.

Authors:  Ying-fei Lu; Li Zhang; Mary Miu Yee Waye; Wei-ming Fu; Jin-fang Zhang
Journal:  Exp Cell Res       Date:  2015-04-07       Impact factor: 3.905

6.  The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer.

Authors:  Ji Luo; Lewis C Cantley
Journal:  Cell Cycle       Date:  2005-10-28       Impact factor: 4.534

Review 7.  Novel therapies for metastatic renal cell carcinoma: efforts to expand beyond the VEGF/mTOR signaling paradigm.

Authors:  Sumanta Kumar Pal; Stephen Williams; David Y Josephson; Courtney Carmichael; Nicholas J Vogelzang; David I Quinn
Journal:  Mol Cancer Ther       Date:  2012-02-17       Impact factor: 6.261

8.  A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.

Authors:  Ankur K Nagaraja; Chad J Creighton; Zhifeng Yu; Huifeng Zhu; Preethi H Gunaratne; Jeffrey G Reid; Emuejevoke Olokpa; Hiroaki Itamochi; Naoto T Ueno; Shannon M Hawkins; Matthew L Anderson; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2010-01-15

9.  miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.

Authors:  Shou-Mei Yang; Cheng Huang; Xiao-Feng Li; Ming-Zhe Yu; Yong He; Jun Li
Journal:  Toxicology       Date:  2013-03-04       Impact factor: 4.221

10.  MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.

Authors:  Ying Wang; Xiushan Zheng; Zhiyong Zhang; Jinfeng Zhou; Guohong Zhao; Jianjun Yang; Limin Xia; Rui Wang; Xiqiang Cai; Hao Hu; Cailin Zhu; Yongzhan Nie; Kaichun Wu; Dexin Zhang; Daiming Fan
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

View more
  23 in total

Review 1.  Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters.

Authors:  Mehdi Rabiee Valashedi; Chia Bamshad; Nima Najafi-Ghalehlou; Amirsadegh Nikoo; Kazuo Tomita; Yoshikazu Kuwahara; Tomoaki Sato; Amaneh Mohammadi Roushandeh; Mehryar Habibi Roudkenar
Journal:  Hum Cell       Date:  2022-04-12       Impact factor: 4.174

2.  A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.

Authors:  Hanieh Sadeghi; Aryan Kamal; Marzieh Ahmadi; Hadi Najafi; Ali Sharifi Zarchi; Peyman Haddad; Bahareh Shayestehpour; Leila Kamkar; Masoumeh Salamati; Loabat Geranpayeh; Marzieh Lashkari; Mehdi Totonchi
Journal:  RNA Biol       Date:  2021-11-18       Impact factor: 4.652

Review 3.  NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes.

Authors:  Ilona M Gora; Anna Ciechanowska; Piotr Ladyzynski
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

4.  Molecular mechanism of miR-181b in heart disease due to pregnancy-induced hypertension syndrome.

Authors:  Zheng Gao; Li Wang; Jinyun Wang; Fengyong Yang; Jin Qu
Journal:  Exp Ther Med       Date:  2017-08-03       Impact factor: 2.447

Review 5.  MicroRNAs and obesity-induced endothelial dysfunction: key paradigms in molecular therapy.

Authors:  Karima Ait-Aissa; Quynh My Nguyen; Mohanad Gabani; Adam Kassan; Santosh Kumar; Soo-Kyoung Choi; Alexis A Gonzalez; Tahsin Khataei; Amal M Sahyoun; Cheng Chen; Modar Kassan
Journal:  Cardiovasc Diabetol       Date:  2020-09-09       Impact factor: 9.951

6.  Associations between maternal lifetime stressors and negative events in pregnancy and breast milk-derived extracellular vesicle microRNAs in the programming of intergenerational stress mechanisms (PRISM) pregnancy cohort.

Authors:  Anne K Bozack; Elena Colicino; Rodosthenis Rodosthenous; Tessa R Bloomquist; Andrea A Baccarelli; Robert O Wright; Rosalind J Wright; Alison G Lee
Journal:  Epigenetics       Date:  2020-08-25       Impact factor: 4.528

7.  MicroRNA-486-5p Suppresses Lung Cancer via Downregulating mTOR Signaling In Vitro and In Vivo.

Authors:  Lei Ding; Wu Tian; Hui Zhang; Wanqiu Li; Chunyu Ji; Yuanyuan Wang; Yanli Li
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

Review 8.  mTOR signaling-related MicroRNAs and Cancer involvement.

Authors:  Ping Wang; Xiao-Min Liu; Lei Ding; Xin-Ju Zhang; Zhong-Liang Ma
Journal:  J Cancer       Date:  2018-01-08       Impact factor: 4.207

9.  High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids.

Authors:  Ida Rapa; Arianna Votta; Gaia Gatti; Stefania Izzo; Nicola Lo Buono; Elisa Giorgio; Simona Vatrano; Francesca Napoli; Aldo Scarpa; Giorgio Scagliotti; Mauro Papotti; Marco Volante
Journal:  Oncotarget       Date:  2018-06-08

Review 10.  Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.

Authors:  Arun Samidurai; Rakesh C Kukreja; Anindita Das
Journal:  Oxid Med Cell Longev       Date:  2018-08-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.